Form 8-K - Current report:
SEC Accession No. 0001193125-25-249854
Filing Date
2025-10-24
Accepted
2025-10-24 15:13:17
Documents
10
Period of Report
2025-10-22
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20251022.htm   iXBRL 8-K 59646
  Complete submission text file 0001193125-25-249854.txt   194628

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20251022.xsd EX-101.SCH 42847
12 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20251022_htm.xml XML 5600
Mailing Address 5956 SHERRY LANE 20TH FLOOR DALLAS TX 75225
Business Address 5956 SHERRY LANE 20TH FLOOR DALLAS TX 75225 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 251415878
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)